AI Article Synopsis
Article Abstract
The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jocn.2014.03.029 | DOI Listing |
Publication Analysis
Top Keywords
acute ischaemic
8
ischaemic stroke
8
intravenous thrombolysis
4
thrombolysis acute
4
stroke setting
4
setting rivaroxaban
4
rivaroxaban risk
4
risk thrombolysis
4
thrombolysis patients
4
patients novel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!